CD38 is upregulated in mouse models of lung cancer and melanoma that have acquired resistance to anti‐PD‐1/anti‐PD‐L1 blockade, and correlates with CD8+ T‐cell impairment.28, 29, 37. Here, CD38 is linked to lung cancer.